|
| 37962685 | Branchioma: immunohistochemical and molecular genetic study of 23 cases highlighting frequent loss of retinoblastoma 1 immunoexpression. | Virchows Arch | 2024 |
| 37962685 | Branchioma: immunohistochemical and molecular genetic study of 23 cases highlighting frequent loss of retinoblastoma 1 immunoexpression. | Virchows Arch | 2024 |
| 36938641 | Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples. | Cancer Cytopathol | 2023 |
| 37664452 | Predicting breast cancer-specific survival in metaplastic breast cancer patients using machine learning algorithms. | J Pathol Inform | 2023 |
| 37927461 | Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report. | Front Oncol | 2023 |
| 37970806 | Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast Cancer Brain Metastasis. | Mol Pharm | 2023 |
| 37479706 | Obesity-associated changes in molecular biology of primary breast cancer. | Nat Commun | 2023 |
| 37405466 | Whole Genome Sequencing in Advanced Lung Cancer can be Performed Using Diff-Quik Cytology Smears Derived from Endobronchial Ultrasound, Transbronchial Needle Aspiration (EBUS TBNA). | Lung | 2023 |
| 37144467 | Redefining normal breast cell populations using long noncoding RNAs. | Nucleic Acids Res | 2023 |
| 36579383 | Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast. | Histopathology | 2023 |
| 36958289 | The Queensland IMplementation of PRecision Oncology in brEast cancer (Q-IMPROvE) pilot study. | Med J Aust | 2023 |
| 37072858 | COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. | J Exp Clin Cancer Res | 2023 |
| 36999648 | BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme. | Histopathology | 2023 |
| 36938641 | Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples. | Cancer Cytopathol | 2023 |
| 36468287 | Survey of recurrent diagnostic challenges in breast phyllodes tumours. | Histopathology | 2023 |
| 36468211 | Hereditary breast cancer: syndromes, tumour pathology and molecular testing. | Histopathology | 2023 |
| 37366040 | Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. | Histopathology | 2023 |
| 37664452 | Predicting breast cancer-specific survival in metaplastic breast cancer patients using machine learning algorithms. | J Pathol Inform | 2023 |
| 37479706 | Obesity-associated changes in molecular biology of primary breast cancer. | Nat Commun | 2023 |
| 37927461 | Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report. | Front Oncol | 2023 |
| 37970806 | Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast Cancer Brain Metastasis. | Mol Pharm | 2023 |
| 36958289 | The Queensland IMplementation of PRecision Oncology in brEast cancer (Q-IMPROvE) pilot study. | Med J Aust | 2023 |
| 37144467 | Redefining normal breast cell populations using long noncoding RNAs. | Nucleic Acids Res | 2023 |
| 37405466 | Whole Genome Sequencing in Advanced Lung Cancer can be Performed Using Diff-Quik Cytology Smears Derived from Endobronchial Ultrasound, Transbronchial Needle Aspiration (EBUS TBNA). | Lung | 2023 |
| 37072858 | COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. | J Exp Clin Cancer Res | 2023 |
| 37366040 | Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. | Histopathology | 2023 |
| 36999648 | BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme. | Histopathology | 2023 |
| 36579383 | Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast. | Histopathology | 2023 |
| 36468287 | Survey of recurrent diagnostic challenges in breast phyllodes tumours. | Histopathology | 2023 |
| 36468211 | Hereditary breast cancer: syndromes, tumour pathology and molecular testing. | Histopathology | 2023 |
| 35057759 | Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content. | BMC Cancer | 2022 |
| 36228963 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer. | Ann Oncol | 2022 |
| 35501337 | Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer. | NPJ Breast Cancer | 2022 |
| 36147610 | Prospective Optimization of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Lymph Node Assessment for Lung Cancer: Three Needle Agitations Are Noninferior to 10 Agitations for Adequate Tumor Cell and DNA Yield. | JTO Clin Res Rep | 2022 |
| 35993751 | Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells. | J Vis Exp | 2022 |
| 35778289 | The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in point. | Pathology | 2022 |
| 36497221 | NDRG1 in Cancer: A Suppressor, Promoter, or Both? | Cancers (Basel) | 2022 |
| 35225863 | Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases-From Biology to Clinical Utility. | Diseases | 2022 |
| 35158800 | Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases. | Cancers (Basel) | 2022 |
| 35008424 | Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients. | Cancers (Basel) | 2022 |
| 35346112 | N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease. | BMC Cancer | 2022 |
| 35057759 | Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content. | BMC Cancer | 2022 |
| 35346112 | N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease. | BMC Cancer | 2022 |
| 35501337 | Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer. | NPJ Breast Cancer | 2022 |
| 35778289 | The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in point. | Pathology | 2022 |
| 36497221 | NDRG1 in Cancer: A Suppressor, Promoter, or Both? | Cancers (Basel) | 2022 |
| 36147610 | Prospective Optimization of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Lymph Node Assessment for Lung Cancer: Three Needle Agitations Are Noninferior to 10 Agitations for Adequate Tumor Cell and DNA Yield. | JTO Clin Res Rep | 2022 |
| 35993751 | Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells. | J Vis Exp | 2022 |
| 36228963 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer. | Ann Oncol | 2022 |
| 35225863 | Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases-From Biology to Clinical Utility. | Diseases | 2022 |